Regarding this hypothesis, we have shown that metformin failed to suppress basal tumor growth in 4T1-bearing mice, but suppressed both growth and phosphorylated-mTOR/S6K levels in 4T1 mammary tumors, but only when co-administered with a DPP-4 inhibitor [29]. Here, RPS6KB1 is linked to neoplasm.